Movement Characterization in Spastic/Dystonic Cerebral Palsy Using Haptic

Status Recruiting

Clinical Trial Summary

This game-like intervention using virtual reality will provide an objective and quantitative characterization of dystonia and spasticity presentations in cerebral palsy, even if combined, through the process of motor learning. This intervention could have a therapeutic benefit in the rehabilitation of children with cerebral palsy.

Clinical Trial Description

Cerebral palsy is the most common developmental motor disorder in children. Individuals with cerebral palsy demonstrate abnormal muscle tone and motor control. Within the population of children with cerebral palsy, between 4% and 17% present dystonic symptoms and between 80% to 95% of cases present spasticity. In many cases spasticity and dystonia are present in the same child and accurate diagnosis may be challenging.

This study consists of a randomized controlled trial that uses a virtual reality game-based intervention incorporating fully-automated robotic haptic feedback to aid the the objective, quantitative diagnosis of spasticity and dystonia u=in CP. The study consists of face-to-face assessments of movement before, after, and one-month following the completion of the six-session game-based intervention. Children with spastic/dystonic cerebral palsy and typically developing children between the ages of 7 and 17 will be recruited for this study. The investigators anticipate to recruit a total of 68 participants, 34 with cerebral palsy and 34 typically developing. Both groups of children will be randomly allocated into an intervention or control group using a blocked randomization method. Movement outcomes will be examined for changes in quantitative and clinical measures in children with spastic/dystonic cerebral palsy and typically developing children to aid on the classification of movement disorders. Pair t-tests will be conducted on movement outcomes for both groups of children independently. Positive and negative results will be reported and addressed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03744884
Study type	Interventional
Source	University of Illinois at Urbana-Champaign
Contact	Citlali Lopez-Ortiz, PhD
Phone	217-300-1022
Email	lopezort@illinois.edu
Status	Recruiting
Phase	N/A
Start date	December 1, 2018
Completion date	January 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04530955` - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)	N/A
Not yet recruiting	`NCT05131724` - Effectiveness of Virtual Reality on Functional Mobility During Treadmill Training in Children With Cerebral Palsy	N/A
Completed	`NCT03005938` - Influence of the Spinal Manipulation on Muscle Spasticity and Manual Dexterity in Cerebral Palsy.	N/A
Completed	`NCT04087330` - Whole-body Vibration in Spastic Hemiplegic Cerebral Palsy	N/A
Completed	`NCT04570358` - Stretching in Children and Adolescents With Spastic Cerebral Palsy	N/A
Completed	`NCT05945953` - Incentive Spirometer as a Visual Feedback in Children With Spastic Cerebral Palsy	N/A
Completed	`NCT03209310` - The Effect of Trunk Control on Respiratory Muscle Strength	N/A
Recruiting	`NCT03361930` - Changes in Muscle Activity of Children With Spastic Unilat Cerebral Palsy Using 2 Types of Ankle-foot Orthoses to Walk	N/A
Recruiting	`NCT05593887` - Late-presenting Hip Dislocation in Non-ambulatory Children With Cerebral Palsy: A Comparison of Three Procedures	N/A
Recruiting	`NCT03677843` - Multidimensional Approach in Patients With Severe Cerebral Palsy, Prospective Cohort(MAPCP Cohort)-Offline
Recruiting	`NCT03179241` - Outcome After Selective Dorsal Rhizothomy Concerning Life Quality, Cerebral Imaging and Cognition
Recruiting	`NCT05627921` - The Effect of Botulinum Toxin and ESWT Applications on Spasticity and Functionality in Cerebral Palsy Patients	N/A
Completed	`NCT05102955` - Turkish Validity and Reliability of the Visual Function Classification System (VFCS)
Recruiting	`NCT06330922` - Muscle-tendon Pathology and Metabolic Dysregulation in CP
Completed	`NCT05251532` - The Efficacy of Distortion Banding on Outcome Measures in Children With Cerebral Palsy	N/A
Completed	`NCT05251519` - The Efficacy of Derotation Banding on Outcome Measures in Children With Cerebral Palsy	N/A
Completed	`NCT05115695` - The Effect of Upper Extremity Strengthening on Functionality, Muscle Strength and Trunk in Children With Cerebral Palsy	N/A
Completed	`NCT04240275` - Reliability of a Body-worn Sensor System for Gait Analysis in Children With CP
Not yet recruiting	`NCT05198921` - The Effectiveness of Repetitive Transcranial Magnetic Stimulation for Spastic Diplegia Cerebral Palsy	N/A
Completed	`NCT03212846` - Muscle Spasticity Reduction in Children With Cerebral Palsy by Means of Hippotherapy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Movement Characterization in Spastic/Dystonic Cerebral Palsy Using Haptic Feedback in Virtual Reality

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms